Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...

Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /CNW/ - Specific Biologics Inc. ("Specific"), a ...

Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...

To use this evidence, investigators typically must grow the larvae until adulthood in a laboratory setting and then identify ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each warehouse.

Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...

The rapid development of artificial intelligence (AI) technology has become a cornerstone of multidisciplinary research worldwide, establishing a new paradigm of "AI for Science." AI is progressively ...

Inborn errors of immunity (IEI), formerly known as primary immunodeficiencies, represent a heterogeneous group of more than 480 genetic disorders ...